Redmile Group, LLC Replimune Group, Inc. Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
A detailed history of Redmile Group, LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 5,562,096 shares of REPL stock, worth $57.7 Million. This represents 3.26% of its overall portfolio holdings.
Number of Shares
5,562,096
Previous 3,729,983
49.12%
Holding current value
$57.7 Million
Previous $30.5 Million
64.27%
% of portfolio
3.26%
Previous 1.2%
Shares
22 transactions
Others Institutions Holding REPL
# of Institutions
153Shares Held
70MCall Options Held
26.7KPut Options Held
28.6K-
Baker Bros. Advisors LP New York, NY10MShares$104 Million1.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.24MShares$95.8 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$50.5 Million6.46% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$48.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$32.3 Million0.01% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $511M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...